Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal (Colon or Rectal) Cancer”

1,311 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,311 results

Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Large-scale testing (Phase 3)Looking for participantsNCT06791512
What this trial is testing

MFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Who this might be right for
Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang 166
Not applicableStudy completedNCT04776837
What this trial is testing

Predicting Disease Progression and/or Recurrence in Cancer

Who this might be right for
Patient Reported Outcome MeasuresColorectal CancerPancreatic Cancer+5 more
Massachusetts General Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT02654639
What this trial is testing

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Georgetown University 4
Testing effectiveness (Phase 2)Study completedNCT00569699
What this trial is testing

Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

Who this might be right for
Colorectal Cancer
Taiho Pharmaceutical Co., Ltd. 56
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Not applicableEnded earlyNCT01466504
What this trial is testing

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaColorectal Carcinoma
Dartmouth-Hitchcock Medical Center 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT05185947
What this trial is testing

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+7 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Looking for participantsNCT07321106
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal Cancer (CRC)Colorectal (Colon or Rectal) Cancer+4 more
Cartography Biosciences 80
Not applicableStudy completedNCT01830647
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Cancer of the Colon or Rectum

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 35
Testing effectiveness (Phase 2)Study completedNCT00022698
What this trial is testing

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 67
Large-scale testing (Phase 3)Study completedNCT00706121
What this trial is testing

S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000

Who this might be right for
Colorectal CancerPrecancerous Condition
SWOG Cancer Research Network 8,094
Large-scale testing (Phase 3)Study completedNCT01640405
What this trial is testing

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 350
Large-scale testing (Phase 3)Study completedNCT00303771
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 282
Not applicableUnknownNCT02665312
What this trial is testing

Cardiotoxicity and Risk Factors in Patients With Colorectal Cancer Receiving Fluoropyrimidine

Who this might be right for
Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 200
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT03965234
What this trial is testing

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Who this might be right for
Metastatic Bone SarcomaMetastatic Malignant Neoplasm in the LungMetastatic Soft Tissue Sarcoma+3 more
Roswell Park Cancer Institute 99
Early research (Phase 1)Study completedNCT00343408
What this trial is testing

AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerLung Cancer
NCIC Clinical Trials Group 31
Early research (Phase 1)Looking for participantsNCT06756035
What this trial is testing

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Who this might be right for
Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more
Context Therapeutics Inc. 70
Load More Results